.Nature Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medicine conjugate (ADC) tisotumab vedotin caused boosted progression-free as well as total survival, resulting in FDA approval and also a brand-new procedure possibility for people.